Kleiner Perkins Caufield & Byers XV LLC 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 4:53 pm Sale |
2021-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
Kleiner Perkins Caufield & Byers XV LLC | 1,297,063 4.400% |
-650,000 (-33.38%) |
Filing |
| 2021-02-16 11:44 am Sale |
2020-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
Kleiner Perkins Caufield & Byers XV LLC | 1,947,063 7.900% |
-1,600,000 (-45.11%) |
Filing |